GSK

GlaxoSmithKline and Vir Biotechnology Jump in Race to Treat and Prevent COVID-19
GlaxoSmithKline and Vir Biotechnology Jump in Race to Treat and Prevent COVID-19
Motley Fool
GSK
Vir Biotechnology
vaccines
COVID-19
Flag link:
GSK allies with Innovax for COVID-19 vaccine R&D project
GSK allies with Innovax for COVID-19 vaccine R&D project
Fierce Biotech
GSK
Xiamen Innovax Biotech
vaccines
COVID-19
Flag link:
GSK's asthma biologic Nucala is one step closer to approval in key chronic rhinosinusitis population
GSK's asthma biologic Nucala is one step closer to approval in key chronic rhinosinusitis population
Endpoints
GSK
Nucala
rhinosinusitis
nasal polyps
clinical trials
Flag link:
Experts weigh in on vaccine prospects as dozens of COVID-19 projects race ahead
Experts weigh in on vaccine prospects as dozens of COVID-19 projects race ahead
Fierce Pharma
vaccines
COVID-19
Sanofi
Pfizer
GSK
Moderna Therapeutics
Flag link:
FDA moots virtual AdComms but delays GSK, Intercept meetings
FDA moots virtual AdComms but delays GSK, Intercept meetings
Fierce Biotech
FDA
advisory panels
GSK
Intercept Pharma
Flag link:
Pharma giants including Novartis collaborate on COVID-19 therapies
Pharma giants including Novartis collaborate on COVID-19 therapies
Pharmaforum
JNJ
Novartis
Boehringer Ingelheim
Biomerieux
Eisai
Eli Lilly
Gilead Sciences
GSK
Merck
Merck KGaA
Pfizer
Sanofi
R&D
COVID-19
diagnostics
vaccines
Flag link:
GlaxoSmithKline consumer hiving off Canada plant with 400 workers to Taiwan CDMO
GlaxoSmithKline consumer hiving off Canada plant with 400 workers to Taiwan CDMO
Fierce Pharma
GSK
Bora Pharmaceuticals
CDMOs
drug manufacturing
consumer health
Canada
Flag link:
GSK's ViiV touts 2-month HIV data as sister injection Cabenuva awaits FDA redemption
GSK's ViiV touts 2-month HIV data as sister injection Cabenuva awaits FDA redemption
Fierce Pharma
HIV
FDA
GSK
Cabenuva
ViiV
Flag link:
These nine companies are working on coronavirus treatments or vaccines — here’s where things stand
These nine companies are working on coronavirus treatments or vaccines — here’s where things stand
Marketwatch
Gilead Sciences
GSK
Innovio
JNJ
Moderna Therapeutics
Regeneron
Sanofi
Takeda
Vir Biotchnology
Flag link:
Big Pharma grounds employees: GSK, Bristol, Roche, Sanofi and more limit travel due to coronavirus
Big Pharma grounds employees: GSK, Bristol, Roche, Sanofi and more limit travel due to coronavirus
Fierce Pharma
COVID-19
coronaviruses
Roche
GSK
Bristol-Myers Squibb
Sanofi
Boehringer Ingelheim
Amgen
Biogen
Mylan
Flag link:
GSK’s Walmsley gets £2.5m pay rise after strong 2019
GSK’s Walmsley gets £2.5m pay rise after strong 2019
Pharmaforum
GSK
Emma Walmsley
executive pay
Pharma CEOs
women executives
Flag link:
FDA approves GSK’s Advil Dual Action with Acetaminophen OTC pain reliever
FDA approves GSK’s Advil Dual Action with Acetaminophen OTC pain reliever
Pharmaceutical Business Review
GSK
FDA
OTC
Advil Dual Action with Acetaminophen
Flag link:
Certain GSK antibiotic brands are up for sale — report
Certain GSK antibiotic brands are up for sale — report
Endpoints
GSK
antibiotics
Flag link:
Who were biopharma's Q4 growth stars? Vertex, thanks to a new launch, plus Alexion, Regeneron and GSK
Who were biopharma's Q4 growth stars? Vertex, thanks to a new launch, plus Alexion, Regeneron and GSK
Fierce Pharma
Vertex Pharmaceuticals
Alexion
Regeneron
GSK
earnings
Flag link:
GSK, Innoviva seek EMA approval for Trelegy Ellipta to treat asthma in adults
GSK, Innoviva seek EMA approval for Trelegy Ellipta to treat asthma in adults
Pharmaceutical Business Review
GSK
Innoviva
EMA
Europe
asthma
Trelegy Elipta
Flag link:
Pharmacquired: Where are all the deals?
Pharmacquired: Where are all the deals?
BioPharma Dive
M&A
Gilead Sciences
Biogen
Sanofi
Eli Lilly
GSK
Merck
Vertex Pharmaceuticals
Flag link:
FDA Accepts GSK's sNDA for Zejula as a First-Line Maintenance Treatment in Ovarian Cancer
FDA Accepts GSK's sNDA for Zejula as a First-Line Maintenance Treatment in Ovarian Cancer
BioSpace
GSK
Zejula
ovarian cancer
FDA
Flag link:
Stada Buys 15 Over-the-Counter Products from GSK for $325 Million
Stada Buys 15 Over-the-Counter Products from GSK for $325 Million
BioSpace
GSK
consumer health
OTC
Stada
Flag link:
A Chinese biotech partners with GSK to boost its coronavirus vaccine development
A Chinese biotech partners with GSK to boost its coronavirus vaccine development
Stat
China
GSK
vaccines
coronavirus
Clover BioPharmaceuticals
Flag link:
FDA's Advisory Committee to Review Claims That GlaxoSmithKline's Trelegy Ellipta Reduces Mortality
FDA's Advisory Committee to Review Claims That GlaxoSmithKline's Trelegy Ellipta Reduces Mortality
Motley Fool
GSK
FDA
advisory panels
COPD
Trelegy Ellipta
Flag link:

Pages